Mayo Clinic Health Manager
Get free personalized health guidance for you and your family.
Get Started
close window
Housecall Archives
About our e-newsletters
- Free e-newsletters
- Mayo Clinic expertise
- We do not share your e-mail address
Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with timely, reliable, practical information, recipes, blogs, questions and answers with Mayo Clinic experts and more. Our biweekly topic-specific e-newsletters also include blogs, questions and answers with Mayo Clinic experts, and other useful information that will help you manage your health.
Housecall Archives
close window
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Risk factors
By Mayo Clinic staffStevens-Johnson syndrome is a rare and unpredictable reaction. No test is available to help predict who is at greater risk. Some factors, however, may increase your risk of developing Stevens-Johnson syndrome:
- Existing medical conditions. Viral infections, diseases that decrease your immunity, human immunodeficiency virus (HIV) and systemic lupus erythematosus — a chronic inflammatory disease — increase your risk of developing Stevens-Johnson syndrome.
- Genetics. Carrying a gene called HLA-B12 may make you more susceptible to Stevens-Johnson syndrome.
References
- Tonneson MG. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. In: Rakel RE, et al. Conn's Current Therapy 2008. 60th ed. Philadelphia, Pa.: Saunders Elsevier; 2008. http://www.mdconsult.com/das/book/body/122833403-4/0/1621/0.html. Accessed Feb. 26, 2009.
- The Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum of disease. In: Habif TP. Habif: Clinical Dermatology. 4th ed. St. Louis, Mo.: Mosby; 2006. http://www.mdconsult.com/das/book/body/122833403-5/808553136/1195/120.html. Accessed Feb. 26, 2009.
- Stevens-Johnson syndrome. In: Ferri FF. Ferri's Clinical Advisor 2009. St. Louis, Mo.: Mosby; 2008. http://www.mdconsult.com/das/book/body/122833403-5/0/1417/1201.html. Accessed Feb. 26, 2009.
- Knowles SR, et al. Recognition and management of severe cutaneous drug reactions. Dermatologic Clinics. 2007;25:245.
- Schneck J, et al. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study. Journal of the American Academy of Dermatology. 2008;58:33.
- High WA. Stevens-Johnson syndrome and toxic epidermal necrolysis in adults. http://www.uptodate.com/home/index.html. Accessed Feb. 26, 2009.
